Position in IVA
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$55,500
New position
Shares Held
10,000
first reported quarter
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026BLAIR WILLIAM & CO/IL holds $126,358,113 across 56 Biotechnology names. IVA ranks #52 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
864,329 | $45,169,833 | |
| 2 | ARGX |
Argenx SE
|
22,407 | $16,362,711 | |
| 3 | VKTX |
Viking Therapeutics, Inc.
|
371,119 | $12,076,212 | |
| 4 | EXEL |
Exelixis, Inc.
|
193,238 | $8,287,977 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
16,541 | $7,386,218 | |
| 6 | SLDB |
Solid Biosciences Inc.
|
651,216 | $4,688,755 | |
| 7 | NGNE |
Neurogene Inc.
|
168,218 | $3,391,274 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,430 | $3,120,104 |
All Filings in IVA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $55,500 | 10,000 | Shares | Sole | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||